The ubiquitin-homology gene PIC1: Characterization of mouse (Pic1) and human (UBL1) genes and pseudogenes

Genomics

Volumn 47, Issue 1, 1998, Pages 92-100

  Howe, Kathy ^a   Williamson, Jill ^b   Boddy, Nick ^b   Sheer, Denise ^b   Freemont, Paul ^b   Solomon, Ellen ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; UBIQUITIN; UBIQUITIN HOMOLOGY DOMAIN PROTEIN PIC 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOGENE;

ANIMALIA; MURINAE; RODENTIA;

EID: 0031913121     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1997.5091     Document Type: Article

References (46)

1. Ascoli C. A., Maul G. G. Identification of a novel nuclear domain. J. Cell Biol. 112:1991;785-795.
2. Boddy M. N., Howe K., Etkin L. D., Solomon E., Freemont P. S. PIC-1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukemia. Oncogene. 13:1996;971-982.
3. Brown M. T. Sequence similarities between the yeast chromosome segregation protein Mif2 and the mammalian centromere protein CENP-C. Gene. 160:1995;111-116.
4. Brown M. T., Goetsch L., Hartwell L. H. Mif2 is required for mitotic spindle integrity during anaphase spindle elongation inSaccharomyces cerevisiae. J. Cell Biol. 123:1993;387-403.
5. Carlton M. B. L., Colledge W. H., Evans M. J. Generation of a pseudogene during retroviral infection. Mamm. Genome. 6:1995;90-95.
6. Chelbi-Alix M. K., Pelicano L., Quignon F., Koken M. H. M., Venturini L., Stadler M., Pavlovic J., Degos L., de The H. Induction of the PML protein by interferons in normal and APL cells. Leukemia. 9:1995;2027-2033.
7. Daniel M. T., Koken M., Romagne O., Barbey S., Bazarbachi A., Stadler M., Guillemin M. C., Degos L., Chomienne C., de The H. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood. 82:1993;1858-1867.
8. Dyck J. A., Maul G. G., Miller W. H., Chen J. D., Kakizuka A., Evans R. M. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell. 76:1994;333-343.
9. Epstein A. Immunobiochemical characterization with monoclonal antibodies of Epstein-Barr virus-associated early antigens in chemically induced cells. J. Virol. 50:1984;372-379.
10. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity [addendum]. Anal. Biochem. 137:1984;266-267.
11. Gottlicher M., Heck S., Doucas V., Wade E., Kullmann M., Cato A. C. B., Evans R. M., Herrlich P. Interaction of the ubc9 human homolog with c-jun and with the glucocorticoid receptor. Steroids. 61:1996;257-262.
12. Grignani F., Fagioli M., Alcalay M., Longo L., Pandolfi P. P., Donti E., Biondi A., Lo CoCo C. F., Pelicci P. G. Acute promyelocytic leukemia - From genetics to treatment. Blood. 83:1994;10-25.
13. Guldner H. H., Szostecki C., Grotzinger T., Will H. IFN enhances expression of Sp100, an autoantigen in primary biliary cirrhosis. J. Immunol. 149:1992;4067-4073.
14. Ioannou P. A., Amemiya C. T., Garnes J., Kroisel P. M., Shizuya H., Chen C., Batzer M., de Jong P. J. A new bacteriophage P1-derived vector for the propagation of large human DNA fragments. Nature Genet. 6:1994;84-89.
15. Javahery R., Khachi A., Lo K., Zenzie-Gregory B., Smale S. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol. Cell. Biol. 14:1994;116-127.
16. Jentsch S. The ubiquitin-conjugation system. Annu. Rev. Genet. 26:1992;179-207.
17. Jiang W. D., Koltin Y. 2 hybrid interaction of a human ubc9 homolog with centromere proteins ofSaccharomyces cerevisiae. Mol. Gen. Genet. 251:1996;153-160.
18. Johns M. B. Jr., Paulus-Thomas J. E. Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol. Anal. Biochem. 180:1989;276-278.
19. Koken M. H. M., Puvion-Dutilleul F., Guillemin M. C., Viron A., Linarescruz G., Stuurman N., de Jong L., Szostecki C., Calvo F., Chomienne C., Degos L., Puvion E., de The H. The t(15;17) translocation alters a nuclear-body in a retinoic acid-reversible fashion. EMBO J. 13:1994;1073-1083.
20. Korioth F., Gieffers C., Maul G. G., Frey J. Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J. Cell Biol. 130:1995;1-13.
21. Kozak M. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J. Biol. Chem. 30:1991;19867-19870.
22. Kumar S., Yoshida Y., Noda M. Cloning of a cDNA which encodes a novel ubiquitin-like protein. Biochem. Biophys. Res. Commun. 195:1993;393-399.
23. Mahajan R., Delphin C., Guan T. L., Gerace L., Melchior F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear-pore complex protein ranbp2. Cell. 88:1997;97-107.
24. Matunis M. J., Coutavas E., Blobel G. A novel ubiquitin-like modification modulates the partitioning of the ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear-pore complex. J. Cell Biol. 135:1996;1457-1470.
25. Maul G. G., Guldner H. H., Spivack J. G. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J. Gen. Virol. 74:1993;2679-2690.
26. Maul G. G., Yu E., Ishov A. M., Epstein A. L. Nuclear domain-10 (nd10) associated proteins are also present in nuclear-bodies and redistribute to hundreds of nuclear sites after stress. J. Cell. Biochem. 59:1995;498-513.
27. Meluh P. B., Koshland D. Evidence that theMIF2Saccharomyces cerevisiae. Mol. Biol. Cell. 6:1995a;793-807.
28. Meluh P. B., Koshland D. Suppressors ofMIF2Saccharomyces cerevisiae. Mol. Biol. Cell. 6:1995b;2095.
29. Monier K., Usson Y., Mongelard F., Szepetowski P., Robert-Nicoud M., Vourc'h C. Metaphase and interphase mapping by FISH: Improvement of chromosome banding and signal resolution in interphase nuclei by means of iterative deconvolution. Cytogenet. Cell Genet. 72:1996;200-204.
30. Okura T., Gong L., Kamitani T., Wada T., Okura I., Wei C.-F., Chang H.-M., Yeh E. T. H. Protection against Fas/APO-1 and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J. Immunol. 157:1996;4277-4281.
31. Puvion-Dutilleul F., Chelbi-Alix M. K., Koken M., Quignon F., Puvion E., de The H. Adenovirus infection induces rearrangements in the intranuclear distribution of the nuclear body-associated PML protein. Exp. Cell Res. 218:1995;9-16.
32. Ragoussis J., Senger G., Trowsdale J., Campbell I. G. Genomic organization of the human folate receptor genes on chromosome 11q13. Genomics. 14:1992;423-430.
33. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
34. Sawyer J. R., Moore M. M., Hozier J. C. High resolution G-banded chromosomes of the mouse. Chromosoma. 95:1987;350-358.
35. Shen Z. Y., Pardington-Purtymun P. E., Comeaux J. C., Moyzis R. K., Chen D. J. Ubl1, a human ubiquitin-like protein associating with human rad51/rad52 proteins. Genomics. 36:1996a;271-279.
36. Shen Z., Pardington-Purtymun P. E., Comeaux J. C., Moyzis R. K., Chen D. C. Associations of UBE21 with RAD52, UBL1, p53 and RAD51 proteins in a yeast two-hybrid system. Genomics. 37:1996b;183-186.
37. Sternsdorf T., Guldner H. H., Szostecki C., Grotzinger T., Will H. 2 nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary-cirrhosis. Scand. J. Immunol. 42:1995;257-268.
38. Stuurman N., De Graaf A., Floore A., Josso A., Humbel B., De Jong L., van Driel R. A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J. Cell Sci. 101:1992;773-784.
39. Szostecki C., Guldner H. H., Netter H. J., Will H. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J. Immunol. 145:1990;4338-4347.
40. Tchenio T., Segalbendirdjian E., Heidmann T. Generation of processed pseudogenes in murine cells. EMBO J. 12:1993;1487-1497.
41. Wang Z. Y., Qiu Q. Q., Seufert W., Taguchi T., Testa J. R., Whitmore A., Callen D. F., Welsh D., Shenk T., Deuel T. F. Molecular cloning of the cDNA and chromosome localization of the gene for human ubiquitin-conjugating enzyme-9. J. Biol. Chem. 271:1996;24811-24816.
42. Watanabe T. K., Fujiwara T., Kawai A., Shimizu F., Takami S., Hirano H., Okuno S., Ozaki K., Takeda S., Shimada Y., Nagata M., Takaichi A., Takahashi E., Nakamura Y., Shin S. Cloning, expression, and mapping ofUBE21. Cytogenet. Cell Genet. 72:1996;86-89.
43. Weis K., Rambaud S., Lavau C., Jansen J., Carvalho T., Carmofonseca M., Lamond A., Dejean A. Retinoic acid regulates aberrant nuclear-localization of PML-RAR-alpha in acute promyelocytic leukemia cells. Cell. 76:1994;345-356.
44. Wright D. A., Futcher B., Ghosh P., Geha R. S. Association of human fas (CD95) with a ubiquitin-conjugating enzyme (UBC-FAP). J. Biol. Chem. 271:1996;31037-31043.
45. Xie K. W., Lambie E. J., Snyder M. Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol. Cell. Biol. 13:1993;6170-6179.
46. Zuber M., Heyden T. S., Lajouspetter A. M. A human autoantibody recognizing nuclear matrix-associated nuclear-protein localized in dot structures. Biol. Cell. 85:1995;77-86.